Market Effects of Adverse Regulatory Events: Evidence from Drug Relabeling

Higgins, Matthew John; Yan, Xin; Chatterjee, Chirantan

doi:10.3386/w24957

Local TagsRelease HistoryDetailsSummary

Market Effects of Adverse Regulatory Events: Evidence from Drug Relabeling

Higgins, M. J., Yan, X., & Chatterjee, C. (2019). Market Effects of Adverse Regulatory Events: Evidence from Drug Relabeling. NBER Working Paper, No. 24957.

Item is Released

show all hide all

Basic

show hide

Item Permalink: https://hdl.handle.net/21.11116/0000-0005-7C71-1 Version Permalink: https://hdl.handle.net/21.11116/0000-0005-7C72-0

Genre: Paper

Files

show Files

Locators

show

Creators

show

hide

Creators:
Higgins, Matthew John¹, Author
Yan, Xin², Author
Chatterjee, Chirantan², Author

Affiliations:
1MPI for Innovation and Competition, Max Planck Society, ou_2035292
2External Organizations, ou_persistent22

Content

show

Details

show

hide

Language(s): eng - English

Dates: Date issued: 2019

Publication Status: Issued

Pages: 71

Publishing info: -

Table of Contents: -

Rev. Type: -

Identifiers: DOI: 10.3386/w24957

Degree: -

Event

show

Legal Case

show

Project information

show

Source 1

show

hide

Title: NBER Working Paper

Source Genre: Series

Creator(s):

Affiliations:

Publ. Info: -

Pages: - Volume / Issue: No. 24957 Sequence Number: - Start / End Page: - Identifier: -